Literature DB >> 28619509

miR-141-3p inhibits fibroblast proliferation and migration by targeting GAB1 in keloids.

Jingjuan Feng1, Siliang Xue2, Qiuyu Pang3, Zhen Rang3, Fan Cui4.   

Abstract

Keloids are benign dermal fibroproliferative tumors that develop as a result of several dysregulated processes. Emerging evidence has revealed that miRNAs contribute to keloid formation. However, the molecular mechanisms of keloid pathogenesis remain unclear. In our study, we found that miR-141-3p in keloid tissues and keloid fibroblasts was significantly decreased compared with the levels in normal tissues and normal skin fibroblasts, respectively. miR-141-3p overexpression resulted in significantly decreased proliferation and migration and the promotion of apoptosis in keloid fibroblasts, whereas miR-141-3p knockdown in keloid fibroblasts yielded the opposite results. Growth factor receptor binding 2-associated binding protein 1 (GAB1) was identified and confirmed as a direct target of miR-141-3p. The expression of GAB1 was up-regulated in keloid tissues, and the restoration of GAB1 partially reversed the inhibitory effects of miR-141-3p on the proliferation and migration of keloid fibroblasts. All data suggested that miR-141-3p decreased the proliferation and migration of keloid fibroblasts by repressing GAB1 expression, providing a useful target for keloid management.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GAB1; Keloids; Migration; Proliferation; miR-141-3p

Mesh:

Substances:

Year:  2017        PMID: 28619509     DOI: 10.1016/j.bbrc.2017.06.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

2.  Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.

Authors:  Lechun Lyu; Yu Zhao; Hongquan Lu; Zijie Liu; Jiazhi Guo; Di Lu; Xiang Li
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

Review 3.  Role of MicroRNA in Proliferation Phase of Wound Healing.

Authors:  Amro M Soliman; Srijit Das; Norzana Abd Ghafar; Seong Lin Teoh
Journal:  Front Genet       Date:  2018-02-14       Impact factor: 4.599

4.  Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.

Authors:  Liang Yu; Jin Zhao; Lin Gao
Journal:  Int J Biol Sci       Date:  2018-05-22       Impact factor: 6.580

5.  AMF siRNA treatment of keloid through inhibition signaling pathway of RhoA/ROCK1.

Authors:  Yi Tian; Lan Jin; Wenhong Zhang; Zumeng Ya; Yuan Cheng; Hongyun Zhao
Journal:  Genes Dis       Date:  2018-05-18

6.  Integrated analysis of microRNA and mRNA expression profiles in splenomegaly induced by non-cirrhotic portal hypertension in rats.

Authors:  Junji Saruwatari; Chao Dong; Teruo Utsumi; Masatake Tanaka; Matthew McConnell; Yasuko Iwakiri
Journal:  Sci Rep       Date:  2018-12-20       Impact factor: 4.379

7.  LncRNA MALAT1 promotes wound healing via regulating miR-141-3p/ZNF217 axis.

Authors:  Zun-Hong Liang; Yun-Chuan Pan; Shi-Shuai Lin; Zhi-Yang Qiu; Zhi Zhang
Journal:  Regen Ther       Date:  2020-10-16       Impact factor: 3.419

8.  Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and UL138 Expression through Modulation of Epidermal Growth Factor Receptor Signaling Pathways.

Authors:  Meaghan H Hancock; Jennifer Mitchell; Felicia D Goodrum; Jay A Nelson
Journal:  mSphere       Date:  2020-08-05       Impact factor: 4.389

9.  BTXA regulates the epithelial-mesenchymal transition and autophagy of keloid fibroblasts via modulating miR-1587/miR-2392 targeted ZEB2.

Authors:  Zhanying Hou; Feixiang Fan; Po Liu
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

Review 10.  Epigenetic modification mechanisms involved in keloid: current status and prospect.

Authors:  Wenchang Lv; Yuping Ren; Kai Hou; Weijie Hu; Yi Yi; Mingchen Xiong; Min Wu; Yiping Wu; Qi Zhang
Journal:  Clin Epigenetics       Date:  2020-11-26       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.